ACCELERON PHARMA INC Insider Trading for May 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for May 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 2015 | XLRN | ACCELERON PHARMA I ... | MCGUIRE TERRANCE | Director | Sell | J | 0.00 | 5,079 | 0 | 1,705,412 | 1.7 M to 1.7 M (-0.30 %) |
| May 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 5.08 | 1,600 | 8,128 | 23,896 | |
| May 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 0.48 | 4,000 | 1,920 | 12,000 | |
| May 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 32.20 | 1,400 | 45,080 | 14,100 | 15.5 K to 14.1 K (-9.03 %) |
| May 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 32.41 | 5,600 | 181,496 | 32,004 | 37.6 K to 32 K (-14.89 %) |
| May 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 5.08 | 1,600 | 8,128 | 37,604 | 36 K to 37.6 K (+4.44 %) |
| May 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 0.48 | 4,000 | 1,920 | 36,004 | 32 K to 36 K (+12.50 %) |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 26,500 | |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 31.59 | 1,285 | 40,593 | 57,656 | 58.9 K to 57.7 K (-2.18 %) |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 31.32 | 715 | 22,394 | 58,941 | 59.7 K to 58.9 K (-1.20 %) |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 2,000 | 7,760 | 59,656 | 57.7 K to 59.7 K (+3.47 %) |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.88 | 5,500 | 32,340 | 15,461 | |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 31.81 | 3,900 | 124,059 | 15,000 | 18.9 K to 15 K (-20.63 %) |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 31.06 | 1,600 | 49,696 | 18,900 | 20.5 K to 18.9 K (-7.80 %) |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.88 | 5,500 | 32,340 | 20,500 | 15 K to 20.5 K (+36.67 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCGUIRE TERRANCE | Director | Sell | J | 0.00 | 503,991 | 0 | 2,117,747 | 2.6 M to 2.1 M (-19.22 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 72,251 | |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 6,500 | 25,220 | 77,251 | |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 30,000 | 25 K to 30 K (+20.00 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.78 | 1,500 | 47,670 | 25,000 | 26.5 K to 25 K (-5.66 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.40 | 100 | 3,240 | 26,500 | 26.6 K to 26.5 K (-0.38 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.79 | 4,900 | 155,771 | 26,600 | 31.5 K to 26.6 K (-15.56 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 6,500 | 25,220 | 31,500 | 25 K to 31.5 K (+26.00 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 1.80 | 5,000 | 9,000 | 95,000 | |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 3.88 | 20,000 | 77,600 | 62,500 | |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 1.80 | 5,000 | 9,000 | 17,584 | 12.6 K to 17.6 K (+39.73 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.34 | 900 | 29,106 | 12,584 | 13.5 K to 12.6 K (-6.67 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.77 | 19,100 | 606,807 | 13,484 | 32.6 K to 13.5 K (-58.62 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 3.88 | 20,000 | 77,600 | 32,584 | 12.6 K to 32.6 K (+158.93 %) |
| May 11 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 28,500 | |
| May 11 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 5,000 | 19,400 | 57,656 | 52.7 K to 57.7 K (+9.50 %) |